EL
TNYA icon

EWA LLC’s Tenaya Therapeutics TNYA Stock Holding History

EWA LLC’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.2K Sell
28,656
-24
-0.1% -$18 ﹤0.01% 324
2026
Q1 		$19.9K Sell
28,680
-2,742
-9% -$2.02K ﹤0.01% 279
2025
Q4 		$22.4K Buy
31,422
+1,675
+6% +$2.28K 0.01% 258
2025
Q3 		$48.2K Buy
29,747
+83
+0.3% +$84 0.01% 218
2025
Q2 		$18.1K Buy
+29,664
New +$15.1K 0.01% 212

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EWA LLC's TNYA Position: Q2 2026 in Review

EWA LLC reduced its Tenaya Therapeutics (TNYA) stake by 0.08% in Q2 2026, selling an estimated $18 and leaving 28,656 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #324.

EWA LLC first reported a position in TNYA in Q2 2025 and has held it in 5 quarters since. The position peaked at $48.2K in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • EWA LLC held 28,656 shares of Tenaya Therapeutics worth $21.2K as of Q2 2026.
  • EWA LLC sold 24 Tenaya Therapeutics shares in Q2 2026, an estimated $18.
  • Tenaya Therapeutics made up ﹤0.01% of EWA LLC's portfolio in Q2 2026, its #324 holding.
  • EWA LLC first reported a position in Tenaya Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • EWA LLC's Tenaya Therapeutics position peaked at $48.2K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on EWA LLC's 13F filing for Q2 2026, filed 14 Jul 2026.